Germany's Protembis raises $10m series-A round

The syndicate of investors backing the round included US listed medical technology company Abiomed, Seed Fonds III, Mönchengladbach and Coparion, as well as family offices and angel investors.

The company, which develops cerebral protection systems for heart surgery, expects to bring its product to market following this funding round. A first-in-human clinical study has already been conducted, with more testing expected before the market launch.

Company
Founded in 2013, Protembis is a medical devices startup based in Aachen, Germany. It has developed the ProtEmbo cerebral protection system in order to minimise the risk of stroke and other neurological injury in heart-valve interventions. It is a catheter-based filter device that is advanced via the radial artery of the left arm before the start of a transcatheter aortic valve implantation procedure, and removed again at the end of the procedure, in order to prevent the migration of particles to the brain.

People
Protembis – Karl von Mangoldt, Conrad Rasmus (managing directors, founders).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• DACH
• Healthcare
• Germany
• Venture